Armistice Capital’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Armistice Capital’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-250,000	Closed	-$24.2M	–	96
2019 Q3	$24.2M	Buy	250,000 +182,000	+268%	+$18.2M	1.61%	24
2019 Q2	$6.96M	Buy	+68,000	New	+$7.34M	0.44%	45
2018 Q4	–	Sell	-228,000	Closed	-$12.4M	–	107
2018 Q3	$12.4M	Buy	228,000 +78,000	+52%	+$5.33M	0.75%	39
2018 Q2	$12.4M	Sell	150,000 -30,000	-17%	-$2.32M	0.81%	41
2018 Q1	$12M	Buy	+180,000	New	+$10.4M	0.92%	37

Armistice Capital's ONCE Position: Q4 2019 in Review

Armistice Capital sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 250,000 shares — an estimated $24.2M sold.

Armistice Capital first reported a position in ONCE in Q1 2018 and held it in 5 quarters. The position peaked at $24.2M in Q3 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Armistice Capital reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Armistice Capital sold 250,000 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $24.2M.
Armistice Capital first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2018 and held it in 5 quarters.
Armistice Capital's Spark Therapeutics, Inc. Common Stock position peaked at $24.2M in Q3 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Armistice Capital's 13F filing for Q4 2019, filed 14 Feb 2020.